title: Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus.
authors.affiliation: Boston University School of Medicine, Boston, MA jmfranci@bu.edu.
authors.forename: Craig E
authors.initials: CE
authors.lastname: Gordon
authors.affiliation: Boston University School of Medicine, Boston, MA jmfranci@bu.edu.
authors.forename: Swapna
authors.initials: S
authors.lastname: Vantzelfde
authors.affiliation: Boston University School of Medicine, Boston, MA jmfranci@bu.edu.
authors.forename: Jean M
authors.initials: JM
authors.lastname: Francis
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000818:Animals; D018500:Diabetes Insipidus, Nephrogenic / Q000139:chemically induced / Q000188:drug therapy*; D004195:Disease Models, Animal; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000009:adverse effects*; D014556:Urine
chemical_list: D018020:Lithium Compounds; D011619:Psychotropic Drugs; D000086:Acetazolamide